Receptor Tyrosine Kinase EphB4 Is a Survival Factor in Breast Cancer
S. Ram Kumar(University of Southern California), Parkash S. Gill(University of Southern California)
Cited by 190
Related Papers
EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT
|Blood Advances|2017|24